Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of HPV Vaccination on Cervical Cancer Screening in Tuscany
NCT02296255Phase 4Completed
- Sponsor
- Cancer Prevention and Research Institute of Texas
- Start
- Apr 2010
- Primary completion
- May 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of human papillomavirus type 16 L1 capsid protein antigen in Cervical Cancer (CC), human papillomavirus infection, sponsored by Cancer Prevention and Research Institute of Texas. Started Apr 2010; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigen
03
Conditions
Cervical Cancer (CC)human papillomavirus infection
Beyond the preview
Go deeper on NCT02296255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02296255.